Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
"JNJ-64007957" - Google News
Get the latest updates from "JNJ-64007957" - Google News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated about 2 years ago
Teclistamab/Daratumumab Combo Elicits Encouraging Responses in Relapsed/Refractory Myeloma - OncLive
about 2 years ago
Teclistamab/Daratumumab Combo Elicits Encouraging Responses in Relapsed/Refractory Myeloma OncLive
European Approval Sought for Teclistamab in Relapsed/Refractory Multiple Myeloma - OncLive
over 2 years ago
European Approval Sought for Teclistamab in Relapsed/Refractory Multiple Myeloma OncLive
FDA Approval Sought for Teclistamab for Relapsed/Refractory Multiple Myeloma - OncLive
over 2 years ago
FDA Approval Sought for Teclistamab for Relapsed/Refractory Multiple Myeloma OncLive
Multiple Myeloma Industry Landscape, 2030 - GlobeNewswire
over 2 years ago
Multiple Myeloma Industry Landscape, 2030 GlobeNewswire
Multiple Myeloma Industry Landscape, 2030 - GlobeNewswire
over 2 years ago
Multiple Myeloma Industry Landscape, 2030 GlobeNewswire
Multiple Myeloma Industry Landscape, 2030 - GlobeNewswire
over 2 years ago
Multiple Myeloma Industry Landscape, 2030 GlobeNewswire
Genmab: Ready For More Growth In 2022 - Seeking Alpha
over 2 years ago
Genmab: Ready For More Growth In 2022 Seeking Alpha
Genmab: Ready For More Growth In 2022 - Seeking Alpha
over 2 years ago
Genmab: Ready For More Growth In 2022 Seeking Alpha
Thomas G. Martin, MD, Discusses Which Abstracts on BCMA Targeted Therapies He's Excited to See at ASH 2021 - Cancer Network
over 2 years ago
Thomas G. Martin, MD, Discusses Which Abstracts on BCMA Targeted Therapies He's...
9 important updates in blood cancer treatment, research - Healio
over 2 years ago
9 important updates in blood cancer treatment, research Healio
Treating relapsed and refractory multiple myeloma | CPAA - Dove Medical Press
over 2 years ago
Treating relapsed and refractory multiple myeloma | CPAA Dove Medical Press
Multiple Myeloma Market Insight, Epidemiology and Forecast Report 2021-2030 – ResearchAndMarkets.com - Financialbuzz.com
almost 3 years ago
Multiple Myeloma Market Insight, Epidemiology and Forecast Report 2021-2030 – ResearchAndMarkets.com Financialbuzz.com